Clinical Trials List
Protocol NumberrSIFN-01
Not yet recruiting
2013-10-01 - 2015-09-30
Phase I
Terminated2
-
Trial Applicant
CMIC Asia-Pacific
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Chi-Li Chung Division of Thoracic Medicine
- Shih-Hsin Hsiao Division of Thoracic Medicine
- Cheng-I Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Te-Chun Hsia Division of Thoracic Medicine
- Ching-Chan Lin Division of Hematology & Oncology
- Chen-Yuan Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
42 participants
